CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Senju Pharmaceutical Co. Ltd. v. Aurobindo Pharma Ltd.

1:14-cv-00579

Overview

Case Number 1:14-cv-00579
Filing Date 2014-05-02
Status Terminated
Termination Date 2015-03-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Aurobindo Pharma USA Inc. Operating Company

Represented By

1 Attorneys Listed

Richard K. Herrmann

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Aurobindo Pharma Ltd. Operating Company

Represented By

4 Attorneys Listed

Richard K. Herrmann

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Sailesh K. Patel

Email: sailesh.patel@afslaw.com

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500, P.O. Box 2306

Nimita L. Parekh

Email: nparekh@schiffhardin.com

Plaintiff

Kyorin Pharmaceutical Co. Ltd. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Senju Pharmaceutical Co. Ltd. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Allergan Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2014-07-14
1:14-cv-00923

Senju Pharmaceutical Co. Ltd. v. Actavis Inc.

Asserted Patent
Status: DED
U.S. District Court 2011-03-31
1:11-cv-00271

Senju Pharmaceutical Co. Ltd. v. Lupin Limited

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6333045
Aqueous liquid pharmaceutical composition comprised of gatifloxacin
Filed: 1999-08-20
Issued: 2001-12-25
Expired (Term Ended)
Expires: 2019-08-20

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

4

Granted

2

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 1 Motion to Dismiss (FRCP 12(b)(6)) 4

Key Dispositive Motions & Rulings

Motion to Dismiss (FRCP 12(b)(6)) Granted
MEMORANDUM ORDER granting 13 MOTION to Dismiss for Failure to State a Claim and for Lack of Subject Matter Jurisdiction filed by Aurobindo Pharma Ltd.,...
Entry #20 • 2015-03-30 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ANSWERING BRIEF in Opposition re 13 MOTION to Dismiss for Failure to State a Claim and for Lack of Subject Matter Jurisdiction filed by Allergan Inc., Kyorin Ph...
Entry #17 • 2014-08-25 Document →
Motion to Dismiss (FRCP 12(b)(6)) Granted
MOTION to Dismiss for Failure to State a Claim and for Lack of Subject Matter Jurisdiction - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Herrman...
Entry #13 • 2014-08-06 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
OPENING BRIEF in Support re 13 MOTION to Dismiss for Failure to State a Claim and for Lack of Subject Matter Jurisdiction filed by Aurobindo Pharma Ltd., Aurobi...
Entry #14 • 2014-08-06 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Aurobindo to Answer Complaint to August 6, 2014 - filed by Allergan Inc., Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co...
Entry #12 • 2014-07-07 Document →

Docket Entries

(23 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1509246.) - filed by Senju Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Allergan Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 05/02/2014)

Entry #1 • 2014-05-02
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1509246.) - filed by Senju Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Allergan Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 05/02/2014)

Entry #1 • 2014-05-02
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1509246.) - filed by Senju Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Allergan Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 05/02/2014)

Entry #1 • 2014-05-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 05/02/2014)

Entry #2 • 2014-05-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/24/14. Date of Expiration of Patent: 8/20/19.Thirty Month Stay Deadline: 9/24/2016. (cla, ) (Entered: 05/02/2014)

Entry #3 • 2014-05-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc